Ascletis Pharma, Inc.'s total assets for Q4 2024 were ¥2.12B, a decrease of 0.00% from the previous quarter. HK:1672 total liabilities were ¥158.41M for the fiscal quarter, a 0.00% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.